Acinetobacter baumannii ventilator-associated pneumonia: Epidemiology, clinical characteristics, and prognosis factors

International Journal of Infectious Diseases

Volumn 17, Issue 12, 2013, Pages

  Chaari, Anis ^a   Mnif, Basma ^b   Bahloul, Mabrouk ^a   Mahjoubi, Fouzia ^b   Chtara, Kamilia ^a   Turki, Olfa ^a   Gharbi, Nourhene ^a   Chelly, Hedi ^a   Hammami, Adnene ^b   Bouaziz, Mounir ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b UNIVERSITY OF SFAX   (Tunisia)

Author keywords

Acinetobacter baumannii; Epidemiology; Prognosis; Ventilator associated pneumonia

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; COLISTIN; CREATININE; HYPERTENSIVE FACTOR; IMIPENEM; QUINOLONE DERIVATIVE; RIFAMPICIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BLOODSTREAM INFECTION; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; FEMALE; FOLLOW UP; GLASGOW COMA SCALE; HUMAN; HYPERTENSION; HYPOTENSION; INFECTION RISK; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PLEURA EFFUSION; PROGNOSIS; RELAPSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SURVIVOR; TREATMENT DURATION; TUNISIA; UREA NITROGEN BLOOD LEVEL; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER BAUMANNII; EPIDEMIOLOGY; PROGNOSIS; VENTILATOR-ASSOCIATED PNEUMONIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; ODDS RATIO; PNEUMONIA, VENTILATOR-ASSOCIATED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUNISIA; YOUNG ADULT;

EID: 84888439766     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.07.014     Document Type: Article

References (21)

1. Chastre J., Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
2. Tablan O.C., Anderson L.J., Besser R., Bridges C., Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004, 53(RR-3):1-36. CDC; Healthcare Infection Control Practices Advisory Committee.
3. Garnacho-Montero J., Ortiz-Leyba C., Fernández-Hinojosa E., Aldabó-Pallás T., Cayuela A., Marquez-Vácaro J.A., et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 2005, 31:649-655.
4. Garnacho-Montero J., Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 2010, 23:332-339.
5. Brahmi N., Beji O., Abidi N., Kouraichi N., Blel Y., El Ghord H., et al. Epidemiology and risk factors for colonization and infection by Acinetobacter baumannii in an ICU in Tunisia, where this pathogen is endemic. J Infect Chemother 2007, 13:400-404.
6. El-Saed A., Balkhy H.H., Al-Dorzi H.M., Khan R., Rishu A.H., Arabi Y.M. Acinetobacter is the most common pathogen associated with late-onset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia. Int J Infect Dis 2013, 17:e696-e701.
7. Kaliterna V., Goic-Barisic I. The ability of biofilm formation in clinical isolates of Acinetobacter baumannii belonging to two different European clones causing outbreaks in the Split University Hospital. Croatia. J Chemother 2013, 25:60-62.
8. Ayraud-Thévenot S., Huart C., Mimoz O., Taouqi M., Laland C., Bousseau A., et al. Control of multi-drug-resistant Acinetobacter baumannii outbreaks in an intensive care unit: feasibility and economic impact of rapid unit closure. J Hosp Infect 2012, 82:290-292.
9. Chaari A., Zribi E., Dammak H., Ghadoun H., Chtara K., Sfar S., et al. Does selective digestive decontamination prevent ventilator-associated pneumonia in trauma patients?. Am J Ther 2013, (April). PMID=23567785; in press.
10. Fagon J.Y., Chastre J., Hance A.J., Montravers P., Novara A., Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993, 94:281-288.
11. Chang H.C., Chen Y.C., Lin M.C., Liu S.F., Chung Y.H., Su M.C., et al. Mortality risk factors in patients with Acinetobacter baumannii ventilator-associated pneumonia. J Formos Med Assoc 2011, 110:564-571.
12. Le Gall J.R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963.
13. Vincent J.L., de Mendonça A., Cantraine F., Moreno R., Takala J., Suter P.M., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working Group on "Sepsis-related Problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26:1793-1800.
14. Greenspan L., McLellan B.A., Greig H. Abbreviated Injury Scale and Injury Severity Score: a scoring chart. J Trauma 1985, 25:60-64.
15. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996, 153:1711-1725. American Thoracic Society.
16. Kwon K.T., Oh W.S., Song J.H., Chang H.H., Jung S.I., Kim S.W., et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother 2007, 59:525-530.
17. Sunenshine R.H., Wright M.O., Maragakis L.L., Harris A.D., Song X., Hebden J., et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007, 13:97-103.
18. Lisboa T., Diaz E., Sa-Borges M., Socias A., Sole-Violan J., Rodríguez A., et al. The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia. Chest 2008, 134:1208-1216.
19. Joung M.K., Kwon K.T., Kang C.I., Cheong H.S., Rhee J.Y., Jung D.S., et al. Impact of inappropriate antimicrobial therapy on outcome in patients with hospital-acquired pneumonia caused by Acinetobacter baumannii. J Infect 2010, 61:212-218.
20. Kallel H., Hergafi L., Bahloul M., Hakim A., Dammak H., Chelly H., et al. Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study. Intensive Care Med 2007, 33:1162-1167.
21. Rodriguez C.H., De Ambrosio A., Bajuk M., Spinozzi M., Nastro M., Bombicino K., et al. In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones. J Infect Dev Ctries 2010, 4:164-167.